The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations

M Sugawara, S Kadomura, X He, Y Takekuma… - European journal of …, 2005 - Elsevier
The aim of this study was to compare the oral absorption of two weak bases including their
pH-independent controlled-release preparations using an in vitro evaluation system. This …

Improvement of domperidone solubility and dissolution rate by dispersion in various hydrophilic carriers

AE Aboutaleb, SI Abdel-Rahman… - Journal of Applied …, 2016 - japsonline.com
The aim of this work was to improve the solubility and dissolution rate of poorly-soluble,
weakly-basic, anti-emetic drug; domperidone (DMP) using solid dispersion technique …

IDD Technology: Oral Delivery of Water-Insoluble Drugs Using Phospholipid Stabilized Microparticulate IDD Formulations

AK Mishra, MG Vachon, PH Guivarc'h… - Modified-release drug …, 2002 - taylorfrancis.com
Drug insolubility is one of the most intractable problems in new drug development and in
reformulation of existing medications. This chapter describes a novel approach, Insoluble …

Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage

PHL Tran, TTD Tran, JB Park, DH Min, HG Choi… - International journal of …, 2011 - Elsevier
The stability of solid dispersions (SD) during storage is of concern. We prepared the pH-
modulated SD (pSD) and compressed tablets consisting of polyethylene glycol (PEG) 6000 …

Formulation of solid dispersion to improve dissolution and oral bioavailability of poorly soluble dexibuprofen

P Tran, JS Park - Pharmaceutical Development and Technology, 2021 - Taylor & Francis
Dexibuprofen (DEXI) belongs to BCS class II drug with poor aqueous solubility resulting in
poor bioavailability. To enhance solubility and bioavailability of DEXI, DEXI-loaded solid …

Enhanced gastric stability of esomeprazole by molecular interaction and modulation of microenvironmental pH with alkalizers in solid dispersion

H Van Nguyen, N Baek, BJ Lee - International Journal of Pharmaceutics, 2017 - Elsevier
Due to the instability of esomeprazole magnesium dihydrate (EPM), a proton pump inhibitor,
in gastric fluid, enteric-coated dosage form is commonly used for therapeutic application. In …

Dissolution/permeation with PermeaLoop™: experience and IVIVC exemplified by dipyridamole enabling formulations

JB Eriksen, R Messerschmid, ML Andersen… - European Journal of …, 2020 - Elsevier
It is our hypothesis that the presence of an absorptive sink for in-vitro dissolution
experiments is decisive to predict extent and duration of super-saturation of low soluble …

Effects of dissolution medium pH and simulated gastrointestinal contraction on drug release from Nifedipine extended-release tablets

Z Gao, C Ngo, W Ye, JD Rodriguez, D Keire… - Journal of …, 2019 - Elsevier
In contrast to nifedipine matrix-based extended-release dosage forms, the osmotic pump
drug delivery systems have a zero-order drug release independent of external variables …

The roles of acidifiers in solid dispersions and physical mixtures

TTD Tran, PHL Tran, HG Choi, HK Han… - International journal of …, 2010 - Elsevier
The roles of acidifiers in polyvinylpyrrolidone-based solid dispersions and physical mixtures
were originally investigated on dissolution rate of drug, acidifier release, structural …

Dipyridamole bioavailability in subjects with reduced gastric acidity

H Derendorf, CP VanderMaelen… - The journal of …, 2005 - Wiley Online Library
Dipyridamole (DP) is an antiplatelet agent that shows decreased oral bioavailability with
increased gastric pH that occurs with commonly prescribed antacids. An extended‐release …